INTRODUCTION
============

The stroke volume (SV) response to exercise is considered one of the most important indices of heart function.[@b1-cln_66p203] Unfortunately, its direct measurement during exercise requires intravascular catheterization, and therefore is rarely performed in the clinical setting. Consequently, several noninvasive methods to estimate exercise SV have been developed.[@b2-cln_66p203] Recently, attention has been given to the oxygen pulse (O~2~ pulse), a readily available variable obtained during cardiopulmonary exercise testing (CPX), calculated by the ratio of oxygen uptake (VO~2~) and heart rate (HR). The O~2~ pulse has been demonstrated to be a powerful predictor of mortality in patients with cardiovascular diseases[@b3-cln_66p203],[@b4-cln_66p203] and it has been associated to the onset of exercise-induced ischemia.[@b5-cln_66p203],[@b6-cln_66p203] Although clinically useful, the O~2~ pulse is not a simple variable to consider, since it is influenced by many factors that can confound its interpretation, including the presence of diastolic dysfunction,[@b7-cln_66p203] valvular regurgitation,[@b8-cln_66p203] fitness level (athletes may exhibit a plateau in oxygen pulse at higher levels of exercise, likely reflecting a physiological limitation of SV at the upper limits of HR),[@b9-cln_66p203] testing protocol[@b10-cln_66p203] and body dimensions.[@b11-cln_66p203]

Rearranging the terms in the modified Fick equation, we have; VO~2~/HR  =  (CO × Ca~O2~)/HR -- (CO × Cv~O2~)/HR, where CO is cardiac output and Ca~O2~ and Cv~O2~ are the arterial and mixed venous O~2~ contents, respectively. Whipp et al.[@b11-cln_66p203] postulated that O~2~ pulse, when plotted as a function of 1/HR, results in a linear relationship that extrapolates to the asymptotic O~2~ pulse. In other words, during progressive exercise, when VO~2~ changes as a linear function of HR, the O~2~ pulse equals the slope of the VO~2~-HR relationship. This relationship only holds true however, if it is assumed that the product of CO and Cv~O2~ is constant during steady-state work rates as seen in graded exercise testing protocols (e.g.: Bruce protocol) and also that Ca~O2~ is normally constant during exercise. To our knowledge, the O~2~ pulse curve pattern during the now-commonly used non-steady-state (ramp protocol) incremental exercise test has not been well described.

In addition, since SV is directly influenced by body dimensions[@b12-cln_66p203],[@b13-cln_66p203] and O~2~ pulse is related to the SV response to exercise, adjustments for body dimensions or weight should be included in studies aiming to evaluate the O~2~ pulse response to exercise. If only maximal values are considered, overweight or obese subjects would have a superior O~2~ pulse response, which is likely misleading considering the higher prevalence of cardiovascular disease in this particular group. This aspect has been an important limitation of both clinical[@b6-cln_66p203],[@b14-cln_66p203] and physiological studies[@b15-cln_66p203],[@b16-cln_66p203] and requires further exploration.

In the present study, we tested the hypothesis that O~2~ pulse corrected for body weight (hereafter termed relative O~2~ pulse) in response to non-steady-state incremental exercise testing demonstrates a linear pattern in a well controlled data set of subjects referred for exercise testing at our institution. In addition, we tested the hypothesis that the relative O~2~ pulse curve pattern during progressive exercise, expressed by its slope and intercept, remains stable during serial testing under the same clinical conditions and similar drug regimens.

MATERIALS AND METHODS
=====================

Study Population
----------------

We retrospectively studied a sample consisting of 502 adult non-athletes referred, at least twice, for exercise testing for clinical and/or exercise pre-participation reasons at our clinic from January 02, 2001 to October 31 2009. The study was designed to conform to the Declaration of Helsinki and approved by the Institutional Ethics Committee. Inclusion criteria consisted of patients who: a) performed two maximal cycling ramp protocol CPX at least 3 months apart; b) did not change clinical status and regular use of medications that might have affected the cardiovascular response to exercise (such as beta-blockers) at both CPXs. Subjects with valvular heart disease, lung disease, anemia and those who exhibited O~2~ desaturation (more than 4% at maximal effort) during exercise were excluded from the study. In addition, all CPXs stopped early for clinical indications were not considered maximal and were excluded. After applying all inclusion and exclusion criteria, 100 subjects were considered for final analyses (80 men), of whom 50% had coronary artery disease. Baseline clinical characteristics are shown in [Table 1](#t1-cln_66p203){ref-type="table"}. After undergoing the first CPX, 75% of the subjects attended a supervised exercise program at our clinic at least three times a week, while the remaining 25% received advice regarding exercise.

Cardiopulmonary Exercise Testing (CPX)
--------------------------------------

After providing written informed consent, all subjects underwent a symptom-limited CPX using an electronically-braked cycle ergometer (EC-1600; Cat Eye;, Japan or CG-04, Inbrasport, Brazil), according to an individualized ramp protocol designed to allow patients to reach maximum exercise within the desirable range of 8 to 12 minutes.[@b17-cln_66p203],[@b18-cln_66p203] The patients were verbally encouraged to exercise to volitional fatigue, regardless the maximal HR attained. No medications were stopped before the CPX. The electrocardiogram (ECG) (Cardiolife TEC 7100; Nihon-Kohden, Japan; or Elite Ergo PC 3.2.1.5; Micromed, Brazil) was continuously monitored via a single lead (CC5 or CM5). Ventilatory expired gas analysis was obtained by a metabolic system (VO2000; MedGraphics, US). The air flow and oxygen and carbon dioxide sensors were calibrated before each test using 2-liter syringes and gases with known volumes of oxygen, nitrogen, and carbon dioxide concentrations. No test results were classified as indeterminate. All exercise tests were performed, analyzed and reported according to a standardized protocol by a single experienced physician.

Hemodynamic and Ventilatory Assessments
---------------------------------------

The HR was analyzed beat-by-beat and expressed every 10-s. Maximum HR was considered as the highest 10-s average obtained during the CPX. The age-predicted maximum HR was also calculated by the equation \[210-(0.65 × age)\]. [@b19-cln_66p203] Expired ventilatory data were analyzed and expressed at each 10-s. Maximum VO~2~ (VO~2max~) was expressed as the highest 60-s average value obtained during the CPX. The age-predicted VO~2max~ was also calculated according to standard equations. [@b19-cln_66p203] Delta VO~2~/workload was calculated as: VO~2max~ -- resting VO~2~ divided by maximum workload and expressed in mL.min^-1^.watts^-1^. For practical purposes, the resting VO~2~ while sitting on the cycle ergometer was considered to be 3.5 mL.kg^-1^.min^-1^ for all subjects. O~2~ pulse was calculated by dividing VO~2~ by HR obtained every 10-s during CPX. Maximum O~2~ pulse was expressed as the highest 60-s average value and was expressed in milliliters per beat. In addition, this value was expressed as a percentage of age-predicted achieved, which corresponds to the ratio between the predicted values for maximum VO~2~ and maximum HR. In order to remove the influence of body weight on the magnitude of O~2~ pulse response during CPX, its values were then divided by weight in kilograms (relative O~2~ pulse). In order to make the mathematical manipulations of the study easier, all results related to the relative O~2~ pulse were multiplied by 100.

Data management and statistical analyses
----------------------------------------

One of the strategies for testing our hypothesis was to divide the sample into quintiles, according to the results of maximum relative O~2~ pulse obtained during the first CPX. Dividing the sample by quintiles allowed us to compare the stability of relative O~2~ pulse in subjects with different fitness levels and values of maximum relative O~2~ pulse. Paired students t-tests were used to assess the differences for key variables between the first and second CPX, when comparisons were made for the entire sample. A χ^2^ statistics was used for comparisons of categorical variables among quintiles of relative O~2~ pulse. For comparisons made on key variables among quintiles of maximum relative O~2~ pulse, a repeated-measures two-way ANOVA with Greenhouse-Geisser correction [@b20-cln_66p203] was performed, in which CPX (i.e., first versus second CPX) and quintiles of maximum relative O~2~ were the main factors. After excluding the first minute (rest-exercise transition) of the CPX, Pearson\'s product-moment correlations between relative O~2~ pulse and CPX duration were performed for each CPX, in order to test the linearity of the relative O~2~ pulse curve during progressive exercise. After testing the adequacy of linear regression by the magnitude of coefficient of determination of the relative O~2~ pulse, we then calculated the slopes and intercepts among quintiles for both CPX. To compare the slopes and intercepts, a paired student t-test was performed. All continuous data were reported as mean ± SEM or as otherwise indicated. NCSS statistical software (Kayesville, UT) was used to perform all analyses. Statistical significance was set at p\<0.05 for all calculations.

RESULTS
=======

The median time between the first and second CPX was 15 months (minimum and maximum of 5 and 62 months, respectively). [Table 1](#t1-cln_66p203){ref-type="table"} presents the baseline clinical characteristics of all patients divided by quintiles of maximum relative O~2~ pulse. Except for the higher proportion of apparently healthy subjects and lower proportion of coronary artery bypass surgery in the 5^th^ quintile compared to the 2^nd^ quintile (p\<0.05), clinical characteristics were homogeneously distributed among all groups. The proportion of subjects taking beta-blockers differed only between the 4^th^ quintile versus 1^st^ and 3^rd^ quintiles (p\<0.05 for both comparisons).

Demographic characteristics and exercise responses for both CPX are shown in [Table 2](#t2-cln_66p203){ref-type="table"} for the entire sample. No significant differences were found for body weight (p = 0.76). Except for maximum HR (p = 0.53), diastolic blood pressure (p = 0.53) and delta VO~2~/workload (p = 0.14), significant differences were found for all other maximum results when the first and second CPXs were compared; the average increases were 11% and 10% for VO~2max~ and maximum relative O~2~pulse, respectively.

[Table 3](#t3-cln_66p203){ref-type="table"} presents the results of selected key variables divided by quintiles for maximum relative O~2~ pulse. No interactions between factors (quintiles and CPX) were found for any of the variables (p\>0.05; [Table 3](#t3-cln_66p203){ref-type="table"}). No significant differences were found for body weight, maximum HR and delta VO~2~/workload in each quintile (p\>0.05 for all comparisons), except for body weight between first and second CPX in the 5^th^ quintile (p\<0.05). In contrast, when the first and second CPXs were compared in each quintile, significant differences were found for VO~2max~, maximum O~2~ pulse and maximum relative O~2~ pulse (p\<0.05 for all comparisons). When the respective CPX between 1st and 5^th^ quintiles were compared, significant differences were found for all variables (p\<0.05 for all comparisons), except for body weight.

VO~2~ increased in a linear manner relative to HR in both CPX from the second minute to maximum exercise (average R^2^ = 0.84 for both CPX in the entire sample). The average R^2^ between VO~2~ and HR from the onset to the second minute of exercise in both CPX was 0.53. The results of the linear regression between relative O~2~ pulse and CPX time divided by quintiles of maximum relative O~2~ pulse are shown in [Table 4](#t4-cln_66p203){ref-type="table"}. The high coefficient of determination (R^2^) in each quintile reveals the linearity of relative O~2~ pulse, after exclusion of the first minute of CPX. After a median time of 15 months, no significant differences were found for the slopes and intercepts between the first and second CPX in each quintile of maximum relative O~2~ pulse (p\>0.05 for all comparisons; except for intercept comparison in the 5^th^ quintile, p = 0.007). When extremes of quintiles for maximum relative O~2~ pulse (i.e., 1^st^ versus 5^th^ quintiles) were compared, its respective slopes were significantly different (p\<0.05). In a subset analysis, similar results were found when the slopes between the first and second CPX were compared separately in men (p = 0.75) and women (p = 0.24); among subjects taking beta-blockers (p = 0.78) and in subjects with known coronary artery disease (p = 0.31).

[Figure 1](#f1-cln_66p203){ref-type="fig"} shows the relative O~2~ pulse curves as a function of percentage time during first and second CPX for 1^st^ and 5^th^ quintiles. No differences were found between CPXs for each quintile (p\>0.05). The vertical line highlights the linearity of the curves after exclusion of the first 10% of the CPX time.

DISCUSSION
==========

The results of the present study add to the existing body of research showing a linear increase in O~2~ pulse throughout maximal incremental non-steady-state exercise testing. In addition, to our knowledge, this is the first study to demonstrate the stability of the O~2~ pulse curve pattern in a large group of subjects under identical clinical status, who served as their own control in a test-retest design.

Our results are in agreement with previous studies, [@b3-cln_66p203],[@b5-cln_66p203],[@b10-cln_66p203],[@b21-cln_66p203]in that VO~2max~ and maximum O~2~ pulse were within normal limits and were significantly higher in the second CPX (p\<0.05; [Table 2](#t2-cln_66p203){ref-type="table"} and [3](#t3-cln_66p203){ref-type="table"}). Even though the purpose of our study was not to assess the influence of exercise training, the higher values observed for VO~2max~ and maximum O~2~ pulse between tests probably occurred because of the training influence, since almost all the subjects increased their physical activity levels. In addition, an effect due to counseling may have occurred since the remaining 25% of the patients were underwent activity counseling after undergoing their initial CPX.

A strong debate regarding the behavior of the SV response to progressive maximum exercise still exists. [@b9-cln_66p203],[@b22-cln_66p203]-[@b24-cln_66p203] Variations in these studies include a decrease, [@b25-cln_66p203] a plateau [@b26-cln_66p203] or an increase in SV when approaching volitional exhaustion [@b27-cln_66p203] when untrained, moderately trained or heart disease patients are considered. [@b24-cln_66p203] The prospective design and complexity of methods for measuring SV in most studies has generally limited sample sizes, and thus limited the external validity of the results. In addition, different testing protocols (graded or constant), type of ergometer (treadmill or cycle), criteria for termination of the test (exhaustion or pre-determined % of age-predicted maximum HR) and also the lack of control of confounding variables such as body weight have limited the interpretation of previous results. Our results support the concept that SV, estimated by relative the O~2~ pulse response to maximum exercise, increases in a linear fashion throughout exercise in non-athletes as shown by the high R^2^ ([Table 4](#t4-cln_66p203){ref-type="table"}). A decrease or a plateau in relative O~2~ pulse would lead to a reduced R^2^ which was not the case in our results. Our approach was novel in that we excluded the first minute of CPX to calculate the linearity and slopes of relative O~2~ pulse. At the onset of a ramp protocol, the lack of linearity in the intensity increment affects the linear increase of HR as a function of VO~2~ (average R^2^  =  0.53 for both CPX). [@b28-cln_66p203] As a consequence, an artificial upward shift in O~2~ pulse slope occurs at the onset of exercise, as seen in [Figure 1](#f1-cln_66p203){ref-type="fig"} during the first 10% of the test (the slopes are visually different before and after the vertical line). Thus, excluding the first minute of the CPX has an advantage in that it allows the direct use of the O~2~ pulse slope, obviating the need to calculate the VO~2~ and HR slopes. Although linearity was present irrespective of quintile of maximum relative O~2~ pulse (high R^2^ in all quintiles) it is clear that the higher the slope of the relative O~2~ pulse, the higher will be its linearity, as demonstrated by the positive trend shown in the results of R^2^ among quintiles of relative O~2~ pulse ([Table 4](#t4-cln_66p203){ref-type="table"}).

Data have recently emerged in regard to the association between the O~2~ pulse pattern during CPX and the presence of ischemia during exercise [@b5-cln_66p203],[@b6-cln_66p203],[@b29-cln_66p203]. Belardinelli et al. [@b5-cln_66p203] studied 202 patients with known coronary heart disease who underwent both myocardial scintigraphy and cycle CPX. By logistic regression analysis, the only independent predictors of a positive myocardial scintigraphy were O~2~ pulse flattening duration (calculated from the inflection point occurring in VO~2~ as related to work) and the slope of VO~2~/workload. The slope of VO~2~/workload was within normal limits from the start of exercise to a point corresponding to the onset of myocardial ischemia. However, as work rate increased further, an inflection point was evident in most patients with detectable myocardial ischemia, with the cutoff of 3.9 mL.min^-1^.watts^-1^ being the strongest independent predictor according to a hierarchical model. Supporting these results, Chaudhry et al., [@b29-cln_66p203] showed that at the onset of myocardial ischemia, a decrease in the O~2~ pulse with increasing work rate and a abrupt decrease in the slope of VO~2~/workload occurred in a 68 year old woman referred for CPX as part of a preoperative evaluation. The O~2~ pulse patterns observed in these studies are most likely explained by reduced stroke volume at higher intensity exercise due to myocardial ischemia. In contrast, this was not the case in our relatively normal subjects, since delta VO~2~/workload was within normal limits in all quintiles of maximum relative O~2~ pulse ([Table 3](#t3-cln_66p203){ref-type="table"}) and the slopes were significantly different from zero ([Table 4](#t4-cln_66p203){ref-type="table"}).

A novel finding shown by the present study was that, after a median time of 15 months in between first and second CPXs, the relative O~2~ pulse curve pattern remained unchanged as demonstrated by the lack of significant differences in slopes and intercepts regardless the maximum relative O~2~ pulse presented in each quintile ([Table 4](#t4-cln_66p203){ref-type="table"}). The slopes and intercepts were similar despite the significantly higher values of VO~2max~ in second CPX in each quintile of maximum relative O~2~ pulse (on average 1% to 20% higher on the second CPX). This may have occurred because of the lower sub-maximal HR values during the second CPX, as a result of the improved VO~2max~ (possible training or counseling effect). In fact, three possible combinations of VO~2~ and HR kinetics may occur after a period of exercise training, the first being that only the VO~2~ kinetics is modified with training, the second being that only the HR kinetics is modified with training and the third being that both VO~2~ and HR kinetics are modified with training. The first two cases imply that modifications of O~2~ pulse slope only mirrors the modification of VO~2~ or HR kinetics; if such is the case, the relevance of the O~2~ pulse kinetics is limited. On the other hand, as may have occurred in our study ([Tables 3](#t3-cln_66p203){ref-type="table"} and [4](#t4-cln_66p203){ref-type="table"}); when both VO~2~ and HR kinetics are modified, the O~2~ pulse kinetics do not correlate highly with any of these two variables. The results for the O~2~ pulse slopes were similar when comparisons between the first and second CPXs were performed, and were also similar when subsets of subjects were analyzed with known coronary artery disease and those taking beta-blockers, which extend the clinical applications of our results to these subgroups.

Finally, our study adjusted O~2~ pulse by body weight. Given the close relationship between SV and body dimensions, [@b12-cln_66p203],[@b13-cln_66p203] consideration of body dimensions is necessary when evaluating the O~2~ pulse pattern to exercise. Otherwise, an obese subject might misleadingly have a superior O~2~ pulse response when compared, for example, to a lean marathoner. To our knowledge, few studies have taken into account the influence of weight on O~2~ pulse responses to exercise. [@b30-cln_66p203]-[@b32-cln_66p203] This aspect has been an important limitation of both clinical [@b6-cln_66p203],[@b14-cln_66p203] and physiological studies. [@b15-cln_66p203],[@b16-cln_66p203] In a study by Munhoz et al.,[@b6-cln_66p203] 87 patients underwent both myocardial scintigraphy and treadmill CPX in order to compare the O~2~ pulse response to incremental exercise in patients with and without ischemia as detected by myocardial scintigraphy. Although a flattening of the O~2~ pulse response occurred in patients with extensive myocardial ischemia when compared to those with mild ischemia, the authors concluded that O~2~ pulse responses during exercise were not able to discriminate those with and without myocardial ischemia. Caution is in order, however, when interpreting these results, since there were significant differences in the weight of the subjects, which was heavier in those with ischemic responses. It is possible then, that patients with ischemic responses performed better in terms of O~2~ pulse simply because they were heavier. Unfortunately, the authors did not provide information on the relative O~2~ pulse responses, which limits comparisons between subjects with different body weights. The sub-maximal O~2~ pulse has also been reported to be similar between trained and untrained men, when trained men were on average 14 kg lighter than untrained men.[@b16-cln_66p203] Similarly, O~2~ pulse was not significantly different between obese and leaner women when obese women were 18 kg heavier on average than leaner women.[@b15-cln_66p203]

Some limitations are of note in the present study. Even though direct measurements of SV were not made, collectively, the evidence is convincing that O~2~ pulse correlates well with direct measurements of SV. [@b11-cln_66p203],[@b16-cln_66p203],[@b21-cln_66p203],[@b33-cln_66p203],[@b34-cln_66p203] According to the modified Fick equation, O~2~ pulse equals the product of SV and arterio-venous oxygen difference. Since the assessment of arterio-venous oxygen difference requires the placement of invasive catheters, we assumed that arterio-venous oxygen difference increases in a predictable way with respect to workload, reaching an approximate constant peak value at close to maximal intensity.[@b25-cln_66p203],[@b35-cln_66p203] Therefore, after the point where arterio-venous oxygen difference tends to reach its maximum value, any further increase in O~2~ pulse will reflect changes in SV. Finally, although the aim of the present study was not to assess the influence of exercise training of key dependent variables, we cannot exclude the possible influence of the supervised exercise program or counseling on our results. Considering all the above, some caution should be made when interpreting the results of the present study.

Clinical implications
---------------------

The novelty of our study lays in the fact that it was the first study to demonstrate the stability of O~2~ pulse. By showing the O~2~ pulse curve stability after a median time of 15 months in subjects under similar clinical conditions and drug regimens, we reject the hypothesis that factors such as measurement variability inherent to any test (in our case CPX), could affect the O~2~ pulse pattern. This increases in importance considering the established association between O~2~ pulse curve pattern and myocardial ischemia. In other words, if such variability in the O~2~ pulse curve pattern was present, rejecting our hypothesis, it could be difficult to discriminate those with a flat O~2~ pulse curve truly caused by myocardial ischemia from those with a flat curve caused just by variations in measurements inherent to CPX.

CONCLUSIONS
===========

After excluding the first minute of CPX (rest-exercise transition), the relative O~2~ pulse exhibited a linear increase throughout maximum exercise. In addition, in a test-retest design, where subjects served as their own controls, the pattern of relative O~2~ pulse remained stable.
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###### 

Baseline clinical characteristics by quintiles of maximum relative O~2~ pulse.

                                   All (n = 100)   Q1      Q2      Q3      Q4         Q5
  -------------------------------- --------------- ------- ------- ------- ---------- -------
  **Medications**Beta blockers     41              5/20    10/50   5/20    12/60\*‡   9/45
      Calcium channel blockers     16              4/20    4/20    4/20    3/15       1/5
      Nitrates                     10              2/10    2/10    1/5     4/20       1/5
      ACE-inhibitors               14              2/10    3/15    7/35    2/10       0
      Diuretics                    12              6/30    2/10    3/15    0          1/5\*
      Statins                      63              12/60   16/80   13/65   13/65      9/45†
  **Risk factors**                                                                    
      Hypertension                 43              8/40    10/50   9/45    9/45       7/35
      Dyslipidemia                 50              9/45    12/60   10/50   11/55      8/40
      Diabetes                     13              1/5     4/20    3/15    5/25       0
      Obesity (BMI ≥ 30 kg/m^2^)   14              3/15    3/15    3/15    3/15       2/10
  **Medical history/Procedures**                                                      
      Apparently healthy           29              7/35    2/10    5/25    6/30       9/45†
      Coronary Artery Disease      50              8/40    13/65   10/50   12/60      7/35
      CABG                         26              4/20    9/45    6/30    5/25       2/10†
      PTCA                         26              3/15    6/30    7/35    6/30       4/20

CABG, coronary artery bypass graft; PTCA, percutaneous transluminal coronary angioplasty; Q, quintile; \* p \< 0.05 vs. Q1; † p\<0.05 vs. Q2; ‡ p\<0.05 vs. Q3.

###### 

Demographic characteristics and exercise test responses.

  VARIABLE N  =  100                                First CPX     Second CPX    p-value
  ------------------------------------------------- ------------- ------------- ---------
  **Demographic characteristics**                                               
      Age (yr)                                      59 ± 1.2      60 ± 1.3      \<0.001
      Body mass index (kg/m^2^)                     26.9 ± 0.4    26.9 ± 0.4    0.82
      Height (cm)                                   170.4 ± 0.9   170.5 ± 0.9   0.14
      Weight (kg)                                   78.4 ± 1.3    78.5 ± 1.4    0.76
  **Resting Values**                                                            
      Heart rate (beats/min)                        63 ± 1.1      60 ± 1.3      0.01
      Blood pressure (mm Hg)                                                    
          Systolic                                  133 ± 1.5     127 ± 2.3     0.02
          Diastolic                                 77 ± 1.0      72 ± 1.4      \<0.001
  **Maximum Values**                                                            
      Heart rate (beats/min)                        144 ± 2.6     144 ± 2.5     0.53
      Blood pressure (mm Hg)                                                    
          Systolic                                  201 ± 3.1     207 ± 2.6     0.009
          Diastolic                                 91 ± 1.3      91 ± 1.3      0.53
      VO~2~ (mL.kg^-1^.min^-1^)                     25.1 ± 1.0    28.2 ± 1.0    \<0.001
      O~2~ pulse (mL.beat^-1^)                      13.7 ± 0.5    15.2 ± 0.5    \<0.001
      Relative O~2~ pulse (mL.beat^-1^.kg^-1^)      17.4 ± 0.5    19.3 ± 0.5    \<0.001
      % achieved of age predicted O~2~ pulse        110 ± 3.2     128 ± 3.3     \<0.001
      Workload (watts)                              133 ± 6.1     150 ± 6.7     \<0.001
      Delta VO~2~/workload (mL.min^-1^.watts^-1^)   12.9 ± 0.22   13.2 ± 0.31   0.14
  **Exercise duration** (minutes)                   10 ± 0.2      11 ± 0.2      \<0.001

Values are mean ± SEM. VO~2~, oxygen uptake; O~2~, oxygen.

###### 

Cardiopulmonary exercise testing results by quintiles of maximum relative O~2~ pulse.

                        Body Weight   Maximum VO~2~   Maximum heart rate   Maximum O~2~ pulse   Maximum relative O~2~ pulse   Delta VO~2~/workload
  --------------------- ------------- --------------- -------------------- -------------------- ----------------------------- ----------------------
  **Q1 (n = 20)**                                                                                                             
      First CPX         74.2 ± 3.6    16.4 ± 0.6      143 ± 4              8.6 ± 0.4            11.6 ± 0.3                    12.1 ± 0.6
      Second CPX        74.1 ± 3.7    20.2 ± 1.0      143 ± 4              10.6 ± 0.6           14.3 ± 0.6                    13.3 ± 0.7
  **Q2 (n = 20)**                                                                                                             
      First CPX         75.2 ± 3.3    19.5 ± 1.0      138 ± 7              10.8 ± 0.5           14.3 ± 0.1                    12.5 ± 0.4
      Second CPX        74.9 ± 3.6    24.3 ± 1.3      140 ± 6              13.2 ± 0.8           17.6 ± 0.7                    12.9 ± 0.5
  **Q3 (n = 20)**                                                                                                             
      First CPX         82.3 ± 2.7    22.9 ± 0.7      142 ± 6              13.4 ± 0.4           16.3 ± 0.2                    13.0 ± 0.4
      Second CPX        81.5 ± 3.0    26.4 ± 1.3      143 ± 5              15.1 ± 0.6           18.7 ± 0.7                    12.7 ± 0.4
  **Q4 (n = 20)**                                                                                                             
      First CPX         82.2 ± 2.6    27.1 ± 1.5      139 ± 6              16.2 ± 0.6           19.7 ± 0.2                    12.8 ± 0.4
      Second CPX        82.6 ± 5.3    29.6 ± 2.2      139 ± 6              17.8 ± 1.1           21.4 ± 1.1                    12.6 ± 0.4
  **Q5 (n = 20)**                                                                                                             
      First CPX         78.2 ± 2.4    39.9 ± 2.5      159 ± 5              19.5 ± 1.0           24.9 ± 1.0                    13.9 ± 0.5
      Second CPX        79.6 ± 2.5    40.3 ± 2.6      160 ± 6              19.5 ± 1.1           24.4 ± 1.2                    14.8 ± 1.1
  **p value**                                                                                                                 
      Quintile factor   0.018         \<0.001         0.002                \<0.001              \<0.001                       0.021
      CPX factor        0.949         0.004           \<0.843              0.002                \<0.001                       0.312
      Interaction       0.998         0.740           0.999                0.601                0.113                         0.687

Values are mean ± SEM. VO~2~, oxygen uptake; O~2~, oxygen; Q, quintile. \* All results of maximum relative O~2~ pulse were multiplied by 100.

###### 

Linear regression results by quintiles of maximum relative O~2~ pulse.

                   R^2^   Slope\* (95% CI)     Slope p-value versus Q5   Slope p-value 1st vs 2nd CPX   Intercept (95% CI)   Intercept p-value 1st vs 2nd CPX
  ---------------- ------ -------------------- ------------------------- ------------------------------ -------------------- ----------------------------------
  **Q1**                                                                                                                     
      First CPX    0.78   0.61 (0.47 - 0.76)   \<0.001                   0.57                           6.9 (5.8 - 8.0)      0.22
      Second CPX   0.79   0.68 (0.50 - 0.85)   0.04                                                     8.1 (9.1 - 12.3)     
  **Q2**                                                                                                                     
      First CPX    0.75   0.62 (0.43 - 0.80)   0.003                     0.37                           9.4 (8.3 - 10.5)     0.13
      Second CPX   0.78   0.73 (0.56 - 0.90)   0.34                                                     10.7 (9.11 - 14.0)   
  **Q3**                                                                                                                     
      First CPX    0.82   0.68 (0.51 - 0.85)   0.009                     0.27                           10.3 (9.1 - 11.5)    0.82
      Second CPX   0.86   0.79 (0.63 - 0.95)   0.61                                                     10.5 (8.7 - 12.4)    
  **Q4**                                                                                                                     
      First CPX    0.84   0.88 (0.70 - 1.05)   0.36                      0.54                           11.1 (9.7 - 12.5)    0.10
      Second CPX   0.85   0.81 (0.62 - 1.01)   0.79                                                     12.6 (11.0 - 14.2)   
  **Q5**                                                                                                                     
      First CPX    0.90   0.99 (0.82 - 1.15)   \-                        0.12                           12.8 (10.9 - 14.6)   0.007
      Second CPX   0.89   0.85 (0.66 - 1.03)   \-                                                       15.4 (13.6 - 17.1)   

R^2^, coefficient of determination for correlation between Relative O~2~ Pulse and CPX duration; CI, Confidence interval; Q, quintile. \* Slopes significantly different from zero (p\<0.05).
